ATE419533T1 - Verfahren/präparat zur erkennung von pankreaskrebs - Google Patents

Verfahren/präparat zur erkennung von pankreaskrebs

Info

Publication number
ATE419533T1
ATE419533T1 AT03024982T AT03024982T ATE419533T1 AT E419533 T1 ATE419533 T1 AT E419533T1 AT 03024982 T AT03024982 T AT 03024982T AT 03024982 T AT03024982 T AT 03024982T AT E419533 T1 ATE419533 T1 AT E419533T1
Authority
AT
Austria
Prior art keywords
polypeptide
nucleic acid
ukw
sample
compound
Prior art date
Application number
AT03024982T
Other languages
English (en)
Inventor
Malte Buchholz
Thomas Gress
Stephanie Loesch
Ulrich Weidle
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE419533T1 publication Critical patent/ATE419533T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03024982T 2002-10-31 2003-10-29 Verfahren/präparat zur erkennung von pankreaskrebs ATE419533T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02024539 2002-10-31

Publications (1)

Publication Number Publication Date
ATE419533T1 true ATE419533T1 (de) 2009-01-15

Family

ID=32405681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03024982T ATE419533T1 (de) 2002-10-31 2003-10-29 Verfahren/präparat zur erkennung von pankreaskrebs

Country Status (6)

Country Link
US (2) US7429452B2 (de)
EP (1) EP1416279B1 (de)
JP (2) JP4394924B2 (de)
AT (1) ATE419533T1 (de)
DE (1) DE60325541D1 (de)
ES (1) ES2318079T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038904A2 (en) * 2004-08-06 2006-04-13 Applera Corporation Method and compositions for treating diseases targeting e-cadherin
WO2006022690A1 (en) * 2004-08-06 2006-03-02 Applera Corporation Method and compositions for treating diseases targeting cd71
US11001881B2 (en) 2006-08-24 2021-05-11 California Institute Of Technology Methods for detecting analytes
US8048626B2 (en) * 2006-07-28 2011-11-01 California Institute Of Technology Multiplex Q-PCR arrays
US11525156B2 (en) 2006-07-28 2022-12-13 California Institute Of Technology Multiplex Q-PCR arrays
US11560588B2 (en) 2006-08-24 2023-01-24 California Institute Of Technology Multiplex Q-PCR arrays
CA2681899C (en) 2007-03-27 2018-06-19 Immunovia Ab Methods for diagnosis of pancreatic adenocarcinoma, and biomarkers and arrays for use in the same
US8538733B2 (en) 2008-01-25 2013-09-17 Life Technologies Corporation Methods for the analysis of dissociation melt curve data
US9708647B2 (en) 2015-03-23 2017-07-18 Insilixa, Inc. Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays
US9499861B1 (en) 2015-09-10 2016-11-22 Insilixa, Inc. Methods and systems for multiplex quantitative nucleic acid amplification
WO2017155858A1 (en) 2016-03-07 2017-09-14 Insilixa, Inc. Nucleic acid sequence identification using solid-phase cyclic single base extension
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
CN113924041B (zh) 2019-03-14 2024-12-03 因斯利克萨公司 基于时间门控的荧光检测的方法和系统
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US81659A (en) * 1868-09-01 m ax i mi
CA1339709C (en) 1987-02-19 1998-03-10 Scripps Clinic And Research Foundation Monoclonal antibodies to human pancreatic cancer
US5912143A (en) * 1996-12-27 1999-06-15 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a human mage protein homolog
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
JP2004514420A (ja) * 2000-07-20 2004-05-20 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードする核酸

Also Published As

Publication number Publication date
US20090136939A1 (en) 2009-05-28
EP1416279A1 (de) 2004-05-06
US7429452B2 (en) 2008-09-30
JP4394924B2 (ja) 2010-01-06
EP1416279B1 (de) 2008-12-31
JP2009284907A (ja) 2009-12-10
US20040110219A1 (en) 2004-06-10
ES2318079T3 (es) 2009-05-01
DE60325541D1 (de) 2009-02-12
JP2004147656A (ja) 2004-05-27

Similar Documents

Publication Publication Date Title
EP2890815B1 (de) Verfahren zur diagnose und behandlung von krebs
KR101437718B1 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
US20160168649A1 (en) Gene expression predictors of cancer prognosis
WO2012094744A1 (en) Prognostic signature for oral squamous cell carcinoma
RU2008108907A (ru) Способ предсказания ответа на лечение
ATE419533T1 (de) Verfahren/präparat zur erkennung von pankreaskrebs
Dolan et al. Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice
KR102562614B1 (ko) 비침습적 방법을 이용한 치주 질환 진단용 키트
JP3469551B2 (ja) 子宮内膜癌および子宮癌の検出及び監視のための新規な方法
EP3954784A1 (de) Zusammensetzung zur diagnose oder prognose der vorhersage von gliomen sowie verfahren zur bereitstellung von informationen in zusammenhang damit
JP2006523456A (ja) 分子細胞遺伝学的方法を用いる癌連鎖遺伝子および治療標的の確認
JP2009050189A (ja) 抗癌剤の有効性予測方法
US8747867B2 (en) Cancer markers
JP2020522501A (ja) Ｔ−ｄｍ１による癌治療成績の予測方法
KR101238196B1 (ko) 대장암의 간 전이 진단용 조성물 및 그 용도
KR101841673B1 (ko) 유전자의 결실을 이용한 유방암 환자의 예후 예측 방법
CN110468201B (zh) Escc频繁突变基因的靶向测序及其在获得判断escc预后的生物标记物中的应用
KR101786309B1 (ko) 사이클린(Cyclin) D1 b 를 이용한 갑상선암의 진단 방법
CN112813167B (zh) 标志物linc01977及其应用
KR102085663B1 (ko) Wrb 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물
KR102897614B1 (ko) 신규한 MFSD7-ATP5l 융합유전자 및 이의 용도
KR102856145B1 (ko) 말초 t세포 림프종 예후 예측용 신규 바이오마커 및 이의 용도
WO2023002725A1 (en) Biomarkers for a therapy comprising an angiogenesis inhibitor
US20260028678A1 (en) Assessment of biological samples for nucleic acid analysis
KR101370108B1 (ko) 위암 진단용 마커로서 ｈｄａｃ2의 용도

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties